Erythromycin ameliorates cigarette-smoke–induced emphysema and inflammation in rats
Authors:
- Xianshu TanXTXianshu Tan
- Wenjuan KuangWKWenjuan Kuang
- Litao LiuLLLitao Liu
- Lihong WanLWLihong Wan
- 1 June 2012
- journal article
- Published by Elsevier in Translational Research
- Vol. 159 (6) , 464-472
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Erythromycin prevents the pulmonary inflammation induced by exposure to cigarette smokeTranslational Research, 2011
- COPD in ChinaChest, 2011
- Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lungBritish Journal of Pharmacology, 2010
- Chronic obstructive pulmonary disease: Histopathology, inflammation and potential therapiesPulmonary Pharmacology & Therapeutics, 2007
- Immunomodulatory Effects of Erythromycin and its Derivatives on Human T-LymphocyteIn VitroImmunopharmacology and Immunotoxicology, 2007
- Burden and clinical features of chronic obstructive pulmonary disease (COPD)The Lancet, 2004
- Oxidative Stress and Apoptosis Interact and Cause Emphysema Due to Vascular Endothelial Growth Factor Receptor BlockadeAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Alveolar Wall Apoptosis Causes Lung Destruction and Emphysematous ChangesAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Matrix Metalloproteinase-9 in Lung RemodelingAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Cytokines in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2001